Literature DB >> 35535102

Fatigue in Cirrhosis.

Krishnagopal Bhandari1, Dharmesh Kapoor1.   

Abstract

Fatigue is a common symptom in patients with liver disease and has a significant impact on the health-related quality of life (HR-QoL). Its pathogenesis is poorly understood and is considered multifactorial. The liver is central in the pathogenesis of fatigue because it uniquely regulates much of the production, storage, and release of substrate for energy generation. Also, the liver "cross-talks" with the key organs that are responsible for this symptom complex-gut, skeletal muscle, and brain. Fatigue can have both peripheral (i.e., neuromuscular) and central (i.e., resulting from changes in neurotransmission within the brain) components. The treatment strategies for the management of fatigue are behavioral changes and pharmacotherapy, along with dietetic intervention and exercise. However, there is no consensus on management strategies for fatigue in patients with liver disease. This article gives an overview of fatigue as a concept, its pathophysiology, measures to evaluate fatigue in patients with liver disease, the impact of fatigue on chronic liver disease, assessment of fatigue in an appropriate clinical setting, and various interventions to manage fatigue.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6MWD, 6 min walk distance; ACG, anterior cingulate gyrus; ADL, activities of daily living; BBB, blood-brain barrier; BNST, bed nucleus of stria terminalis; CEC, cerebral endothelial cell; CFS, chronic fatigue syndrome; CPET, cardio-pulmonary exercise testing; CRH, corticotropin release hormone; DA, dopamine; FAS, fatigue assessment scale; FIS, fatigue impact scale; FSS, fatigue severity scale; HGS, hand-grip strength; HPA, hypothalamus-pituitary-adrenal; HR-QoL, health-related quality of life; IADL, instrumental activities of daily living; ME, meningo-encephalomyelitis; ME, meningoencephalitis; NAFLD, nonalcoholic fatty liver disease; NM, neuromuscular; NO, nitric oxide; PGE2, prostaglandins; PRO, patient-reported outcomes; PROMIS-F, patient-reported outcome measure information system for fatigue; PSC, primary sclerosing cholangitis; SAMe, S-adenosyl-methionine; SN, substantia nigra; SPPB, short-physical performance battery; VAS-F, visual analog scalefatigue; VTA, ventral tegmental area; central fatigue; chronic liver disease; health-related quality of life [HR-QoL]; iNOS, inducible nitric oxide synthase; patient-related outcomes [PRO]; peripheral fatigue; vmPFC, ventromedial prefrontal cortex

Year:  2021        PMID: 35535102      PMCID: PMC9077229          DOI: 10.1016/j.jceh.2021.08.028

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  25 in total

1.  Factors related to fatigue in patients with cirrhosis before and after liver transplantation.

Authors:  Evangelos Kalaitzakis; Axel Josefsson; Maria Castedal; Pia Henfridsson; Maria Bengtsson; Irene Hugosson; Bengt Andersson; Einar Björnsson
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-11       Impact factor: 11.382

2.  Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.

Authors:  D E J Jones; N Bhala; J Burt; J Goldblatt; M Prince; J L Newton
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

3.  Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment.

Authors:  A Fabi; R Bhargava; S Fatigoni; M Guglielmo; M Horneber; F Roila; J Weis; K Jordan; C I Ripamonti
Journal:  Ann Oncol       Date:  2020-03-12       Impact factor: 32.976

Review 4.  Fatigue in chronic disease.

Authors:  M G Swain
Journal:  Clin Sci (Lond)       Date:  2000-07       Impact factor: 6.124

5.  Fatigue in primary biliary cirrhosis.

Authors:  K Cauch-Dudek; S Abbey; D E Stewart; E J Heathcote
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

6.  Frailty predicts waitlist mortality in liver transplant candidates.

Authors:  J C Lai; S Feng; N A Terrault; B Lizaola; H Hayssen; K Covinsky
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

Review 7.  The spectrum of behaviors influenced by serotonin.

Authors:  I Lucki
Journal:  Biol Psychiatry       Date:  1998-08-01       Impact factor: 13.382

8.  Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review.

Authors:  Mazen Noureddin; Suntje Sander-Struckmeier; José M Mato
Journal:  World J Hepatol       Date:  2020-02-27

Review 9.  Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis.

Authors:  Roger Hilfiker; Andre Meichtry; Manuela Eicher; Lina Nilsson Balfe; Ruud H Knols; Martin L Verra; Jan Taeymans
Journal:  Br J Sports Med       Date:  2017-05-13       Impact factor: 13.800

Review 10.  Importance of fatigue and its measurement in chronic liver disease.

Authors:  Lynn H Gerber; Ali A Weinstein; Rohini Mehta; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

View more
  1 in total

Review 1.  Overview of Complications in Cirrhosis.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.